Pharma ChemOutsourcing 2011 Unveils First Wave of 50 Biotech Chemist Speakers for September 12-15 Show in New Jersey

LONG BRANCH, N.J., Feb. 14, 2011 /PRNewswire/ -- Pharma ChemOutsourcing today launched its 2011 show with the unveiling of the first wave of 50 speakers from a diverse array of biotechnology companies pursuing small molecule drug discovery.  

"The biotechs all have clinical pipelines and their experiences in managing R&D programs with limited capital and human resources demonstrate how they have emerged as the new drug discovery engine," said Mark Alexay, the event organizer.  "Their low-cost business model means they outsource everything except their IP." The speaker list may be found at http://chemoutsourcing.com/speakers.php

"This year only we have implemented a special rate to make the show accessible for all biotechs," continued Alexay.  "Our ultimate goal is to attract chemists from every biotech and medium-sized pharmaceutical company in the world.  To that end we will continue to create very special annual gatherings to meet their needs."  Further pharma and biotech special rate information may be found at http://chemoutsourcing.com/biotech.php

"We already have great relations with the Big Pharma companies like Pfizer, Merck, Bristol-Myers Squibb, and Eli Lilly all of whom we work closely with. In 2011 our efforts are increasingly focused on the members of state biotech association members like those of BioNJ, PA Bio, MassBio, BayBio, and SoCalBio.  The US biotech industry is the world leader - facilitating quality interactions among its leaders is good for business."

Pharma ChemOutsourcing is the annual conference and exhibition focused on US, European, and Asian Sourcing/Outsourcing, Medicinal Chemistry, Process R&D, Chemical Development, Formulation, Finished Products, and new chemical technologies, such as flow chemistry.  China's entry into drug discovery collaborations is one of the hottest 2011 topics. The sessions are held concurrently on 4 parallel tracks and feature 150 speakers. Last year the show attracted 800 attendees and 100 exhibitors.  The 2010 attendee list may be viewed at http://chemoutsourcing.com/attendees.php; the 2011 exhibitor list at http://chemoutsourcing.com/sponsors.php

Every evening is devoted to outdoor receptions and dinners to foster interface among attendees; the 2010 beach party photos may be viewed at http://chemoutsourcing.com/gallery.php

For complete information on Pharma ChemOutsourcing please visit www.chemoutsourcing.com or send us an email at [email protected]

Related press releases on Pharma ChemOutsourcing's small molecule biotech initiative may be accessed at: http://tinyurl.com/6cctvak

http://tinyurl.com/6czwz3v

CONTACT: Mark Alexay, President, ChemOutsourcing, Apaporis LLC, +1-201-452-4023, [email protected]

SOURCE Pharma ChemOutsourcing

Suggested Articles

An oncologist leader RBC Capital Markets interviewed expressed comfort that Trodelvy will succeed in earlier-line TNBC and in HR-positive disease.

Gilead Sciences is the latest drugmaker to settle Justice Department claims that its charity contributions were actually kickbacks.

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.